Status:
COMPLETED
Clinical Application of Non-invasive PGT-A
Lead Sponsor:
Kaohsiung Veterans General Hospital.
Collaborating Sponsors:
Sofiva Genomics Co., Ltd.
Conditions:
Genetic Testing
Eligibility:
FEMALE
30-44 years
Phase:
NA
Brief Summary
The study aims to investigate the difference of in vitro fertilization (IVF) outcomes among non-invasive PGT-A, PGT-A and combined non-invasive PGT-A and PGT-A.
Detailed Description
Background Chromosome abnormality is a leading cause of implantation failure and miscarriage. Chromosome abnormality increases with age, resulting in reduced pregnancy rate. Nowadays, preimplantation ...
Eligibility Criteria
Inclusion
- Infertile women who undergo IVF with PGT
- BMI:18\~30 kg/m2
Exclusion
- Primary ovarian insufficiency
- Congenital uterine anomaly
- Severe male infertility (azoospermia)
- One of the couples with chromosome abnormality
- Malignancy
Key Trial Info
Start Date :
March 24 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT04856696
Start Date
March 24 2021
End Date
December 31 2023
Last Update
August 2 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaohsiung Veterans General Hospital
Kaohsiung City, Taiwan, 81362